Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03539328 |
Title | Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer (MITO27) |
Acronym | MITO27 |
Recruitment | Unknown status |
Gender | female |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | ITA |